Liao Phd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The FDA has granted IO-202 an orphan drug designation for patients with chronic myelomonocytic leukemia.

Onc therapeutics incEuropean hematology association congressLiao phdOnc therapeuticsHematology association congressIo 202Patients with chronic myelomonocytic leukemiaCharlene liao phd